Sihuan Pharmaceutical Holdings Group Ltd. (HKG:0460)

Market Cap	11.62B
Revenue (ttm)	2.30B
Net Income (ttm)	-88.36M
Shares Out	9.08B
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	32.64
Dividend	0.02 (1.73%)
Ex-Dividend Date	Sep 26, 2025

Volume	12,573,000
Average Volume	18,920,470
Open	1.250
Previous Close	1.280
Day's Range	1.250 - 1.280
52-Week Range	0.530 - 1.920
Beta	0.84
RSI	42.47
Earnings Date	Mar 27, 2026

About HKG:0460

Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China and the United States. It operates through three segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The company offers filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care, and others, as well as non- or minimally invasive medical aesthet...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 2,767
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0460

Financial Performance

In 2024, HKG:0460's revenue was 1.90 billion, an increase of 2.18% compared to the previous year's 1.86 billion. Losses were -216.66 million, 301.1% more than in 2023.

Financial numbers in CNY